The specter of generic rivalry has consistently loomed over copyright’s famous drug, Sildenafil, triggering questions about the prospects of similar pharmaceutical stakes. While first periods saw substantial returns, the exclusivity expiration has opened the path for discounted substitutes, possibly diminishing earnings and presenting a genuine … Read More